Intranasal immunization with chitosan microparticles enhances lack-dna vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis

The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery

(2020) Soojin Shim et al.   Marine Drugs

Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis

(2018) Jingjing Guo et al.   Frontiers in Cellular and Infection Microbiology

Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate

(2017) Akira Ainai et al.   VIRAL IMMUNOLOGY

Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size

(2016) Jilei Jia et al.   MOLECULAR PHARMACEUTICS

Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis

(2016) Nataly Pescinalli Stegmiller et al.   VACCINE

Sizing the optimal dimensions of a vaccine delivery system: a particulate matter

(2015) Bram Slütter et al.   Expert Opinion on Drug Delivery

Chitosan-based mucosal adjuvants: Sunrise on the ocean

(2015) Yufei Xia et al.   VACCINE

Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes

(2014) Chompoonuch Sawaengsak et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection

(2013) Satyajit Tripathy et al.   ACTA TROPICA

Protective Humoral Immunity Elicited by a Needle-Free Malaria Vaccine Comprised of a Chimeric Plasmodium falciparum Circumsporozoite Protein and a Toll-Like Receptor 5 Agonist, Flagellin

(2013) Daniel Carapau et al.   INFECTION AND IMMUNITY

Chitosan

(2013) Alan Smith et al.   Human Vaccines & Immunotherapeutics

The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses

(2012) Andres Mori et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Absorption-promoting effects of chitosan in airway and intestinal cell lines: A comparative study

(2012) Driton Vllasaliu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen

(2012) Tuhin Bhowmik et al.   JOURNAL OF DRUG TARGETING

Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis

(2012) DANIEL CLÁUDIO DE OLIVEIRA GOMES et al.   PARASITOLOGY

Nasal Immunity to Staphylococcal Toxic Shock Is Controlled by the Nasopharynx-Associated Lymphoid Tissue

(2011) Stefan Fernandez et al.   Clinical and Vaccine Immunology

Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi

(2011) DANIEL CLAUDIO DE OLIVEIRA GOMES et al.   PARASITOLOGY

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Intranasal Vaccination with Chitosan-DNA Nanoparticles Expressing Pneumococcal Surface Antigen A Protects Mice against Nasopharyngeal Colonization byStreptococcus pneumoniae

(2010) Jianghong Xu et al.   Clinical and Vaccine Immunology

Leishmaniasis vaccines: past, present and future

(2010) Farrokh Modabber   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery

(2009) Noemi Csaba et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics

(2008) Shraddha Kumari et al.   CURRENT DRUG TARGETS